Dr. Maria R. Baer, MD

Dr. Baer practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Baer's NPI, 1700881802, was assigned on June 15, 2005. Dr. Baer graduated from Johns Hopkins University School of Medicine in 1979. Dr. Baer holds Maryland license D65598.

Dr. Baer's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Baer's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baer practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Baer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Baer is licensed in Maryland.

Dmand AI lists chronic anemia, chronic leukemia, lung cancer and lymphoma among the conditions Dr. Baer treats.

CMS data shows 549 Medicare services from Dr. Baer across 9 procedure codes in 2024, for 154 Medicare patients. Medicare paid $44,586 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Dr. Baer in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 32% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baer's median patient age at 62, with 49% women.

In 2024, Dr. Baer wrote 283 Medicare Part D claims for 45 patients. 59% of them were for generic drugs. CMS names the drug for 157 of them, across 10 drugs with 11 or more claims each, at $1,170,507 in total drug cost. In 2023, CMS named 219 claims across 11 drugs.

Dr. Baer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 202 papers to Dr. Baer, published from 2004 to 2025. 2019 was the busiest year, with 15. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols and Remission Induction. Dr. Baer has published most often in J Clin Oncol. Dr. Baer's most frequent co-authors are Ashkan Emadi, MD, PhD, Jonathan E. Kolitz, MD and Richard A. Larson.

Dmand AI links Dr. Baer to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Leukemia, Myeloid. Open Payments lists research payments to Dr. Baer that name 2 trials.

CMS Open Payments shows 11 general payments to Dr. Baer from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Agios Pharmaceuticals, Inc. paid the most, $140. It also lists 40 research payments totaling $99,746 from 2016 to 2021, naming 2 clinical trials.

Dmand AI lists 7 awards for Dr. Baer, most recently America's Top Doctors in 2014.

Dr. Baer graduated from Johns Hopkins University School of Medicine in 1979.

Dr. Baer is in network with 10 carriers, including Excellus BlueCross BlueShield, United Healthcare and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.